Search

Search Constraints

You searched for: Author/Creator Cheng, E

Search Results

5. DOP82 Achievement of steroid-free remission in patients with moderately to severely active Crohn's Disease during treatment with risankizumab. (21st January 2022)

6. DOP83 Normalisation of biomarkers and improvement in clinical outcomes in patients with Crohn's Disease treated with risankizumab in the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies. (21st January 2022)

9. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy. (27th December 2018)